Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Acino Pharma (Pty) Ltd, 106 16th Road, Midrand, 1686
Grantryl 1 mg/1 ml.
Grantryl 3 mg/3 ml.
| Pharmaceutical Form |
|---|
|
Injection. |
GRANTRYL 1 mg/1 ml: Ampoules containing granisetron 1 mg (as hydrochloride) in 1 ml aqueous solution.
GRANTRYL 3 mg/3 ml: Ampoules containing granisetron 3 mg (as hydrochloride) in 3 ml aqueous solution.
Sugar free.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Granisetron |
Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5HT3 receptors). Pharmacological studies have demonstrated that granisetron is effective against nausea and vomiting as a result of cytostatic therapy. |
| List of Excipients |
|---|
|
Citric acid monohydrate |
GRANTRYL 1 mg/1 ml: A clear Type 1 glass ampoule containing a clear colourless solution. The content allows withdrawal of 1 ml.
GRANTRYL 3 mg/3 ml: A clear Type 1 glass ampoule containing a clear colourless solution. The content allows withdrawal of 3 ml.
GRANTRYL 1 mg/1 ml: Packs of 5 × 1 ml Type I glass ampoules, packed in a PVC tray, contained in a cardboard carton
GRANTRYL 3 mg/3 ml: Packs of 5 × 5 ml Type I glass ampoules, packed in a PVC tray, contained in a cardboard carton.
Acino Pharma (Pty) Ltd, 106 16th Road, Midrand, 1686
GRANTRYL 1 mg/1 ml: 44/5.7.2/0892
GRANTRYL 3 mg/3 ml: 44/5.7.2/0893
Registration date: 27 November 2014
| Drug | Countries | |
|---|---|---|
| GRANTRYL | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
